Recep Yagiz
Session
This session explores the cutting-edge frontier of inner ear therapeutics. We will cover groundbreaking innovations, including gene therapy for hereditary deafness, regenerative medicine for hair cell restoration, and novel drug delivery systems for treating hearing and balance disorders.
Outcome Objectives Participants will be able to:
1. Describe emerging gene and cell-based strategies for hearing restoration.
2. Evaluate the potential of next-generation cochlear and vestibular implants.
3. Identify new pharmacological targets and delivery methods for the inner ear.
Background Sensorineural hearing loss and vestibular disorders have long been considered irreversible. Advances in molecular biology and bioengineering are now challenging this paradigm, creating unprecedented opportunities for biological repair and functional restoration of the inner ear.